

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | barbed-end actin filament capping (GO:0051016) | 3.49968478 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 3.36038279 |
| 3 | central nervous system myelination (GO:0022010) | 3.36038279 |
| 4 | negative regulation of cell killing (GO:0031342) | 3.11160483 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11160483 |
| 6 | regulation of extracellular matrix disassembly (GO:0010715) | 3.09495495 |
| 7 | response to laminar fluid shear stress (GO:0034616) | 3.06907580 |
| 8 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.98551620 |
| 9 | positive regulation of histone deacetylation (GO:0031065) | 2.97439219 |
| 10 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96085090 |
| 11 | positive regulation of extracellular matrix organization (GO:1903055) | 2.93241190 |
| 12 | positive regulation of receptor recycling (GO:0001921) | 2.92698789 |
| 13 | hypotonic response (GO:0006971) | 2.82120498 |
| 14 | skin morphogenesis (GO:0043589) | 2.70582542 |
| 15 | semaphorin-plexin signaling pathway (GO:0071526) | 2.67819040 |
| 16 | adenosine receptor signaling pathway (GO:0001973) | 2.63232451 |
| 17 | negative regulation of fatty acid transport (GO:2000192) | 2.59857603 |
| 18 | adaptation of signaling pathway (GO:0023058) | 2.56777355 |
| 19 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.55864933 |
| 20 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.55659578 |
| 21 | focal adhesion assembly (GO:0048041) | 2.54853700 |
| 22 | cell-substrate adherens junction assembly (GO:0007045) | 2.54853700 |
| 23 | basement membrane organization (GO:0071711) | 2.54506710 |
| 24 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.54491415 |
| 25 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.54092480 |
| 26 | protein localization to endosome (GO:0036010) | 2.53003590 |
| 27 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.52494020 |
| 28 | hemidesmosome assembly (GO:0031581) | 2.52021463 |
| 29 | mannose metabolic process (GO:0006013) | 2.51440693 |
| 30 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.49450570 |
| 31 | regulation of ARF GTPase activity (GO:0032312) | 2.48707713 |
| 32 | regulation of extracellular matrix organization (GO:1903053) | 2.47940077 |
| 33 | regulation of early endosome to late endosome transport (GO:2000641) | 2.45781088 |
| 34 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.44213483 |
| 35 | tolerance induction (GO:0002507) | 2.42653916 |
| 36 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.42188242 |
| 37 | dendritic spine morphogenesis (GO:0060997) | 2.39747178 |
| 38 | L-amino acid import (GO:0043092) | 2.38962658 |
| 39 | amino acid import (GO:0043090) | 2.38395862 |
| 40 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.37477057 |
| 41 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.36832666 |
| 42 | stress fiber assembly (GO:0043149) | 2.36793388 |
| 43 | postsynaptic membrane organization (GO:0001941) | 2.36524097 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.35640353 |
| 45 | ensheathment of neurons (GO:0007272) | 2.34199016 |
| 46 | axon ensheathment (GO:0008366) | 2.34199016 |
| 47 | membrane tubulation (GO:0097320) | 2.33189158 |
| 48 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33032831 |
| 49 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33032831 |
| 50 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33032831 |
| 51 | modulation by symbiont of host immune response (GO:0052553) | 2.33032831 |
| 52 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33032831 |
| 53 | modulation by symbiont of host defense response (GO:0052031) | 2.33032831 |
| 54 | negative regulation of stress fiber assembly (GO:0051497) | 2.33013437 |
| 55 | regulation of macrophage cytokine production (GO:0010935) | 2.32411176 |
| 56 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.31203540 |
| 57 | atrioventricular valve morphogenesis (GO:0003181) | 2.29795363 |
| 58 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.29611296 |
| 59 | glomerular visceral epithelial cell development (GO:0072015) | 2.29316119 |
| 60 | response to muramyl dipeptide (GO:0032495) | 2.28961475 |
| 61 | sodium ion export (GO:0071436) | 2.28675249 |
| 62 | protein targeting to plasma membrane (GO:0072661) | 2.26931472 |
| 63 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.26549223 |
| 64 | response to fluid shear stress (GO:0034405) | 2.26467723 |
| 65 | fibril organization (GO:0097435) | 2.26258497 |
| 66 | myelination (GO:0042552) | 2.25176252 |
| 67 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.24495187 |
| 68 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.24340903 |
| 69 | regulation of ARF protein signal transduction (GO:0032012) | 2.23774910 |
| 70 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23400486 |
| 71 | protein heterotrimerization (GO:0070208) | 2.23376424 |
| 72 | oligodendrocyte differentiation (GO:0048709) | 2.22187473 |
| 73 | cell-substrate junction assembly (GO:0007044) | 2.21231763 |
| 74 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.18564226 |
| 75 | extracellular fibril organization (GO:0043206) | 2.18368638 |
| 76 | regulation of p38MAPK cascade (GO:1900744) | 2.17587192 |
| 77 | cell volume homeostasis (GO:0006884) | 2.16177857 |
| 78 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.16132375 |
| 79 | venous blood vessel morphogenesis (GO:0048845) | 2.15091887 |
| 80 | extracellular matrix assembly (GO:0085029) | 2.15063762 |
| 81 | megakaryocyte development (GO:0035855) | 2.14595907 |
| 82 | myelin maintenance (GO:0043217) | 2.13629589 |
| 83 | positive regulation of developmental pigmentation (GO:0048087) | 2.13430427 |
| 84 | glomerular epithelial cell development (GO:0072310) | 2.12820129 |
| 85 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.11039730 |
| 86 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.10856897 |
| 87 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.10856897 |
| 88 | angiogenesis involved in wound healing (GO:0060055) | 2.10645126 |
| 89 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.10323192 |
| 90 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.10323192 |
| 91 | positive regulation of protein dephosphorylation (GO:0035307) | 2.10173884 |
| 92 | positive regulation of p38MAPK cascade (GO:1900745) | 2.10047355 |
| 93 | negative regulation of bone resorption (GO:0045779) | 2.09462930 |
| 94 | endodermal cell differentiation (GO:0035987) | 2.08873146 |
| 95 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.08421718 |
| 96 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.08297808 |
| 97 | regulation of pigment cell differentiation (GO:0050932) | 2.07255921 |
| 98 | apoptotic cell clearance (GO:0043277) | 2.07238598 |
| 99 | response to peptidoglycan (GO:0032494) | 2.07236024 |
| 100 | regulation of interleukin-13 production (GO:0032656) | 2.07232383 |
| 101 | modulation by symbiont of host cellular process (GO:0044068) | 2.07011609 |
| 102 | pinocytosis (GO:0006907) | 2.06650365 |
| 103 | cell-cell junction maintenance (GO:0045217) | 2.06578915 |
| 104 | myelination in peripheral nervous system (GO:0022011) | 2.06231394 |
| 105 | peripheral nervous system axon ensheathment (GO:0032292) | 2.06231394 |
| 106 | endocytic recycling (GO:0032456) | 2.05930964 |
| 107 | germinal center formation (GO:0002467) | 2.05900021 |
| 108 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.05849731 |
| 109 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.05334866 |
| 110 | embryonic process involved in female pregnancy (GO:0060136) | 2.04564108 |
| 111 | epithelial cell-cell adhesion (GO:0090136) | 2.04205721 |
| 112 | ear development (GO:0043583) | 2.03985749 |
| 113 | establishment of apical/basal cell polarity (GO:0035089) | 2.03909961 |
| 114 | negative regulation of Ras GTPase activity (GO:0034261) | 2.03677888 |
| 115 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.03053255 |
| 116 | negative regulation of tissue remodeling (GO:0034104) | 2.02361535 |
| 117 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.02188415 |
| 118 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.01864143 |
| 119 | activation of JUN kinase activity (GO:0007257) | 2.01795751 |
| 120 | cortical actin cytoskeleton organization (GO:0030866) | 2.01680647 |
| 121 | adhesion of symbiont to host cell (GO:0044650) | 2.01616448 |
| 122 | virion attachment to host cell (GO:0019062) | 2.01616448 |
| 123 | apoptotic process involved in morphogenesis (GO:0060561) | 2.01499297 |
| 124 | regulation of monocyte differentiation (GO:0045655) | 2.01461012 |
| 125 | positive regulation of lipid kinase activity (GO:0090218) | 2.01372268 |
| 126 | detection of other organism (GO:0098543) | 2.00683228 |
| 127 | head development (GO:0060322) | 2.00607535 |
| 128 | regulation of leukocyte degranulation (GO:0043300) | 2.00189718 |
| 129 | pattern specification involved in kidney development (GO:0061004) | 1.99903574 |
| 130 | phagocytosis, engulfment (GO:0006911) | 1.99881594 |
| 131 | Rho protein signal transduction (GO:0007266) | 1.99736499 |
| 132 | cellular response to epinephrine stimulus (GO:0071872) | 1.99564582 |
| 133 | polarized epithelial cell differentiation (GO:0030859) | 1.99236945 |
| 134 | substrate-dependent cell migration (GO:0006929) | 1.99036725 |
| 135 | lateral sprouting from an epithelium (GO:0060601) | 1.98943881 |
| 136 | astrocyte differentiation (GO:0048708) | 1.98844311 |
| 137 | detection of molecule of bacterial origin (GO:0032490) | 1.98308851 |
| 138 | positive regulation of metanephros development (GO:0072216) | 1.98144475 |
| 139 | negative regulation of cell-matrix adhesion (GO:0001953) | 1.97992446 |
| 140 | regulation of lipid kinase activity (GO:0043550) | 1.97419157 |
| 141 | filopodium assembly (GO:0046847) | 1.96460713 |
| 142 | positive thymic T cell selection (GO:0045059) | 1.96426025 |
| 143 | actin filament bundle organization (GO:0061572) | 1.96424039 |
| 144 | actin filament bundle assembly (GO:0051017) | 1.96424039 |
| 145 | negative regulation of smooth muscle cell migration (GO:0014912) | 1.96298148 |
| 146 | cortical cytoskeleton organization (GO:0030865) | 1.95862860 |
| 147 | negative regulation of focal adhesion assembly (GO:0051895) | 1.95664550 |
| 148 | negative regulation of cell junction assembly (GO:1901889) | 1.95664550 |
| 149 | negative regulation of adherens junction organization (GO:1903392) | 1.95664550 |
| 150 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.95559057 |
| 151 | signal complex assembly (GO:0007172) | 1.95209548 |
| 152 | mesodermal cell differentiation (GO:0048333) | 1.95197638 |
| 153 | neuron remodeling (GO:0016322) | 1.94974979 |
| 154 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 1.94523227 |
| 155 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 1.94523227 |
| 156 | positive regulation of gliogenesis (GO:0014015) | 1.94284284 |
| 157 | regulation of integrin activation (GO:0033623) | 1.94079644 |
| 158 | positive regulation of Rap GTPase activity (GO:0032854) | 1.93825092 |
| 159 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 1.93416297 |
| 160 | adherens junction assembly (GO:0034333) | 1.93262541 |
| 161 | activated T cell proliferation (GO:0050798) | 1.93023726 |
| 162 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 1.91771817 |
| 163 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.90866454 |
| 164 | epithelial cell fate commitment (GO:0072148) | 1.89479482 |
| 165 | astrocyte development (GO:0014002) | 1.89104790 |
| 166 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 1.88874670 |
| 167 | establishment of monopolar cell polarity (GO:0061162) | 1.88874670 |
| 168 | surfactant homeostasis (GO:0043129) | 1.88343922 |
| 169 | endothelial cell chemotaxis (GO:0035767) | 1.88093607 |
| 170 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 1.88070863 |
| 171 | metanephric nephron epithelium development (GO:0072243) | 1.88042294 |
| 172 | forebrain neuron differentiation (GO:0021879) | 1.87974263 |
| 173 | cellular response to fluid shear stress (GO:0071498) | 1.87830316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.02706895 |
| 2 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.88198789 |
| 3 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.59642508 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.50210703 |
| 5 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.08046427 |
| 6 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.05746611 |
| 7 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.97247968 |
| 8 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.91813184 |
| 9 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.91813184 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.91813184 |
| 11 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.91155709 |
| 12 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.90541112 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88044996 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.87353063 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.86079671 |
| 16 | KDM2B_26808549_Chip-Seq_K562_Human | 1.83064741 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82285214 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.80372379 |
| 19 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.78942430 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.78884458 |
| 21 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.75092381 |
| 22 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.74878765 |
| 23 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.73703031 |
| 24 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71559016 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71253996 |
| 26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71252004 |
| 27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71252004 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.71113715 |
| 29 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69669671 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69538799 |
| 31 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.69537498 |
| 32 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.68655122 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67526259 |
| 34 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.63894224 |
| 35 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.63276263 |
| 36 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.62067830 |
| 37 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.60410561 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.58070995 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56162580 |
| 40 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55068578 |
| 41 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54537330 |
| 42 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53838237 |
| 43 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51637541 |
| 44 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.51008289 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.50638546 |
| 46 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.47477401 |
| 47 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.47042089 |
| 48 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46700452 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45109332 |
| 50 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43292400 |
| 51 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.42477585 |
| 52 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.42213744 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.41957257 |
| 54 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39461230 |
| 55 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.39163160 |
| 56 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.37665797 |
| 57 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.37482323 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37076446 |
| 59 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.35010772 |
| 60 | GATA1_19941826_ChIP-Seq_K562_Human | 1.34881253 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.33266329 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31900691 |
| 63 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.29527968 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26274689 |
| 65 | MYC_22102868_ChIP-Seq_BL_Human | 1.26087619 |
| 66 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.26043446 |
| 67 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.26043446 |
| 68 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.24310587 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23912920 |
| 70 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23819694 |
| 71 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.23748901 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.23442100 |
| 73 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21254778 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.20888083 |
| 75 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.20886119 |
| 76 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.20220914 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.19674283 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18695210 |
| 79 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18550510 |
| 80 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.17711952 |
| 81 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17703556 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.17238636 |
| 83 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16406393 |
| 84 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.15739057 |
| 85 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.15489385 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15349652 |
| 87 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15185237 |
| 88 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.14664804 |
| 89 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13486921 |
| 90 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.13116566 |
| 91 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.12943073 |
| 92 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.12903334 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.12573118 |
| 94 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12135474 |
| 95 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.11605199 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 1.11054770 |
| 97 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11046090 |
| 98 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10511900 |
| 99 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.10504133 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10486084 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.09969415 |
| 102 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09791221 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09671084 |
| 104 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09459834 |
| 105 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.08820955 |
| 106 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.08528456 |
| 107 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.08512948 |
| 108 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.08215124 |
| 109 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07769753 |
| 110 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.06679436 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.05986135 |
| 112 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.05923016 |
| 113 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05552628 |
| 114 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05066781 |
| 115 | * MAF_26560356_Chip-Seq_TH1_Human | 1.05066184 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04898460 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.04346095 |
| 118 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04269912 |
| 119 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03698872 |
| 120 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03578639 |
| 121 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.03176004 |
| 122 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.02391534 |
| 123 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.02155451 |
| 124 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02123522 |
| 125 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01848634 |
| 126 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.01807444 |
| 127 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01528429 |
| 128 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.01307457 |
| 129 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00850186 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00167672 |
| 131 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.99978438 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99469586 |
| 133 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.98767838 |
| 134 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.98362399 |
| 135 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.98193128 |
| 136 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97346389 |
| 137 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.97329023 |
| 138 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97248856 |
| 139 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.97222109 |
| 140 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.96416452 |
| 141 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.95771695 |
| 142 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.95262774 |
| 143 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95104418 |
| 144 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95092449 |
| 145 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94547622 |
| 146 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.92769804 |
| 147 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.92720166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 3.90712417 |
| 2 | MP0004858_abnormal_nervous_system | 2.75624787 |
| 3 | MP0003303_peritoneal_inflammation | 2.46786376 |
| 4 | MP0000751_myopathy | 2.22397773 |
| 5 | MP0000920_abnormal_myelination | 2.11682687 |
| 6 | MP0005623_abnormal_meninges_morphology | 1.98857613 |
| 7 | MP0003300_gastrointestinal_ulcer | 1.96478077 |
| 8 | MP0003075_altered_response_to | 1.86147627 |
| 9 | MP0002254_reproductive_system_inflammat | 1.86009220 |
| 10 | MP0009840_abnormal_foam_cell | 1.80032756 |
| 11 | MP0005503_abnormal_tendon_morphology | 1.79996529 |
| 12 | MP0005275_abnormal_skin_tensile | 1.78236811 |
| 13 | MP0000685_abnormal_immune_system | 1.63734022 |
| 14 | MP0004510_myositis | 1.62349929 |
| 15 | MP0005670_abnormal_white_adipose | 1.61499919 |
| 16 | MP0008961_abnormal_basal_metabolism | 1.61309183 |
| 17 | MP0005075_abnormal_melanosome_morpholog | 1.59050786 |
| 18 | MP0001958_emphysema | 1.58633455 |
| 19 | MP0001348_abnormal_lacrimal_gland | 1.56850524 |
| 20 | MP0005387_immune_system_phenotype | 1.56453918 |
| 21 | MP0001790_abnormal_immune_system | 1.56453918 |
| 22 | MP0005451_abnormal_body_composition | 1.55206539 |
| 23 | MP0003690_abnormal_glial_cell | 1.54497544 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.53158208 |
| 25 | MP0008260_abnormal_autophagy | 1.52994488 |
| 26 | MP0009278_abnormal_bone_marrow | 1.50960559 |
| 27 | MP0004885_abnormal_endolymph | 1.50633518 |
| 28 | MP0004272_abnormal_basement_membrane | 1.48892570 |
| 29 | MP0003172_abnormal_lysosome_physiology | 1.46916599 |
| 30 | MP0003279_aneurysm | 1.45606314 |
| 31 | MP0003634_abnormal_glial_cell | 1.44761373 |
| 32 | MP0003283_abnormal_digestive_organ | 1.43896822 |
| 33 | MP0006082_CNS_inflammation | 1.43583382 |
| 34 | MP0003828_pulmonary_edema | 1.43558141 |
| 35 | MP0005058_abnormal_lysosome_morphology | 1.41835776 |
| 36 | MP0005375_adipose_tissue_phenotype | 1.41658447 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.41391728 |
| 38 | MP0009780_abnormal_chondrocyte_physiolo | 1.38473629 |
| 39 | MP0004859_abnormal_synaptic_plasticity | 1.38238749 |
| 40 | MP0002249_abnormal_larynx_morphology | 1.35366777 |
| 41 | MP0000858_altered_metastatic_potential | 1.34849831 |
| 42 | MP0004270_analgesia | 1.33857564 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.33569235 |
| 44 | MP0003045_fibrosis | 1.31535366 |
| 45 | MP0003938_abnormal_ear_development | 1.30397238 |
| 46 | MP0005076_abnormal_cell_differentiation | 1.29791517 |
| 47 | MP0003091_abnormal_cell_migration | 1.27569647 |
| 48 | MP0001849_ear_inflammation | 1.27204683 |
| 49 | MP0004130_abnormal_muscle_cell | 1.27116682 |
| 50 | MP0001542_abnormal_bone_strength | 1.26903787 |
| 51 | MP0005423_abnormal_somatic_nervous | 1.26595620 |
| 52 | MP0005390_skeleton_phenotype | 1.26568982 |
| 53 | MP0003724_increased_susceptibility_to | 1.24698148 |
| 54 | MP0000049_abnormal_middle_ear | 1.23333618 |
| 55 | MP0004947_skin_inflammation | 1.21898843 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.21682563 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.21446606 |
| 58 | MP0003453_abnormal_keratinocyte_physiol | 1.19903736 |
| 59 | MP0004133_heterotaxia | 1.19596839 |
| 60 | MP0002877_abnormal_melanocyte_morpholog | 1.18882269 |
| 61 | MP0004185_abnormal_adipocyte_glucose | 1.16697816 |
| 62 | MP0005409_darkened_coat_color | 1.16518295 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.14999156 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.14907614 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.13179431 |
| 66 | MP0001851_eye_inflammation | 1.12748380 |
| 67 | MP0006138_congestive_heart_failure | 1.11277313 |
| 68 | MP0002009_preneoplasia | 1.11117829 |
| 69 | MP0002697_abnormal_eye_size | 1.10243825 |
| 70 | MP0000733_abnormal_muscle_development | 1.09528844 |
| 71 | MP0005000_abnormal_immune_tolerance | 1.09363734 |
| 72 | MP0005595_abnormal_vascular_smooth | 1.09181178 |
| 73 | MP0002277_abnormal_respiratory_mucosa | 1.09111468 |
| 74 | MP0003950_abnormal_plasma_membrane | 1.08591384 |
| 75 | MP0002405_respiratory_system_inflammati | 1.08051476 |
| 76 | MP0000778_abnormal_nervous_system | 1.07781393 |
| 77 | MP0005508_abnormal_skeleton_morphology | 1.06403271 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.06105583 |
| 79 | MP0003329_amyloid_beta_deposits | 1.05399475 |
| 80 | MP0004381_abnormal_hair_follicle | 1.04623851 |
| 81 | MP0003436_decreased_susceptibility_to | 1.04564081 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.03772035 |
| 83 | MP0000678_abnormal_parathyroid_gland | 1.01638553 |
| 84 | MP0003136_yellow_coat_color | 0.99960269 |
| 85 | MP0005464_abnormal_platelet_physiology | 0.99537416 |
| 86 | MP0000759_abnormal_skeletal_muscle | 0.99535230 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.98572105 |
| 88 | MP0000343_altered_response_to | 0.98559282 |
| 89 | MP0002060_abnormal_skin_morphology | 0.97743450 |
| 90 | MP0005023_abnormal_wound_healing | 0.96627739 |
| 91 | MP0004087_abnormal_muscle_fiber | 0.95250762 |
| 92 | MP0003879_abnormal_hair_cell | 0.94648214 |
| 93 | MP0000749_muscle_degeneration | 0.94003509 |
| 94 | MP0004883_abnormal_blood_vessel | 0.92919519 |
| 95 | MP0001879_abnormal_lymphatic_vessel | 0.92505403 |
| 96 | MP0002796_impaired_skin_barrier | 0.92333754 |
| 97 | MP0002971_abnormal_brown_adipose | 0.91739987 |
| 98 | MP0003866_abnormal_defecation | 0.91611898 |
| 99 | MP0005164_abnormal_response_to | 0.91260275 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.91215930 |
| 101 | MP0002108_abnormal_muscle_morphology | 0.91068694 |
| 102 | MP0000604_amyloidosis | 0.91058820 |
| 103 | MP0005671_abnormal_response_to | 0.90916508 |
| 104 | MP0004742_abnormal_vestibular_system | 0.90224993 |
| 105 | MP0008438_abnormal_cutaneous_collagen | 0.89852705 |
| 106 | MP0009379_abnormal_foot_pigmentation | 0.88782940 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.88652692 |
| 108 | MP0002064_seizures | 0.88584396 |
| 109 | MP0005025_abnormal_response_to | 0.87012263 |
| 110 | MP0001800_abnormal_humoral_immune | 0.86473522 |
| 111 | MP0005165_increased_susceptibility_to | 0.86434033 |
| 112 | MP0000747_muscle_weakness | 0.86281749 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.85799590 |
| 114 | MP0002452_abnormal_antigen_presenting | 0.85378592 |
| 115 | MP0003448_altered_tumor_morphology | 0.85348444 |
| 116 | MP0008569_lethality_at_weaning | 0.85095258 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.84626803 |
| 118 | MP0002420_abnormal_adaptive_immunity | 0.83350808 |
| 119 | MP0002723_abnormal_immune_serum | 0.82975553 |
| 120 | MP0002925_abnormal_cardiovascular_devel | 0.82814068 |
| 121 | MP0000767_abnormal_smooth_muscle | 0.81317481 |
| 122 | MP0001819_abnormal_immune_cell | 0.80869022 |
| 123 | MP0010630_abnormal_cardiac_muscle | 0.80723314 |
| 124 | MP0003941_abnormal_skin_development | 0.80440202 |
| 125 | MP0003633_abnormal_nervous_system | 0.80423643 |
| 126 | MP0008874_decreased_physiological_sensi | 0.80329780 |
| 127 | MP0000249_abnormal_blood_vessel | 0.80170586 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.79938333 |
| 129 | MP0003635_abnormal_synaptic_transmissio | 0.78928009 |
| 130 | MP0001614_abnormal_blood_vessel | 0.78585523 |
| 131 | MP0010368_abnormal_lymphatic_system | 0.78331713 |
| 132 | MP0002933_joint_inflammation | 0.78098294 |
| 133 | MP0005166_decreased_susceptibility_to | 0.77995892 |
| 134 | MP0002166_altered_tumor_susceptibility | 0.76488579 |
| 135 | MP0003795_abnormal_bone_structure | 0.76280193 |
| 136 | MP0000534_abnormal_ureter_morphology | 0.76254224 |
| 137 | MP0000013_abnormal_adipose_tissue | 0.76133930 |
| 138 | MP0005388_respiratory_system_phenotype | 0.75957265 |
| 139 | MP0002133_abnormal_respiratory_system | 0.75957265 |
| 140 | MP0008004_abnormal_stomach_pH | 0.75342894 |
| 141 | MP0000762_abnormal_tongue_morphology | 0.74990437 |
| 142 | MP0002419_abnormal_innate_immunity | 0.72424049 |
| 143 | MP0001533_abnormal_skeleton_physiology | 0.72081157 |
| 144 | MP0005193_abnormal_anterior_eye | 0.71977956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.76932828 |
| 2 | Obstructive sleep apnea (HP:0002870) | 3.45392168 |
| 3 | Aortic aneurysm (HP:0004942) | 3.30496765 |
| 4 | Diplopia (HP:0000651) | 3.24570624 |
| 5 | Abnormality of binocular vision (HP:0011514) | 3.24570624 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.23799949 |
| 7 | Increased connective tissue (HP:0009025) | 3.17774128 |
| 8 | Split foot (HP:0001839) | 3.16777369 |
| 9 | Distal lower limb muscle weakness (HP:0009053) | 3.08411591 |
| 10 | Increased variability in muscle fiber diameter (HP:0003557) | 3.05035069 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.02909502 |
| 12 | Nuclear cataract (HP:0100018) | 2.92378287 |
| 13 | Peripheral hypomyelination (HP:0007182) | 2.92339717 |
| 14 | Cerebral inclusion bodies (HP:0100314) | 2.88450362 |
| 15 | Atrophic scars (HP:0001075) | 2.88207630 |
| 16 | Aortic dissection (HP:0002647) | 2.82592117 |
| 17 | Broad face (HP:0000283) | 2.79413909 |
| 18 | Milia (HP:0001056) | 2.77905742 |
| 19 | Cervical subluxation (HP:0003308) | 2.71732210 |
| 20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.71494964 |
| 21 | Vertebral compression fractures (HP:0002953) | 2.69054027 |
| 22 | Type 1 muscle fiber predominance (HP:0003803) | 2.67508783 |
| 23 | Muscle fiber splitting (HP:0003555) | 2.59428090 |
| 24 | Cerebral aneurysm (HP:0004944) | 2.56879115 |
| 25 | Distal lower limb amyotrophy (HP:0008944) | 2.56727193 |
| 26 | Spinal rigidity (HP:0003306) | 2.56527798 |
| 27 | Increased cerebral lipofuscin (HP:0011813) | 2.54925904 |
| 28 | Shallow orbits (HP:0000586) | 2.54921115 |
| 29 | Interstitial pulmonary disease (HP:0006530) | 2.53462897 |
| 30 | Aneurysm (HP:0002617) | 2.51620108 |
| 31 | Annular pancreas (HP:0001734) | 2.49104487 |
| 32 | Spondylolisthesis (HP:0003302) | 2.48229718 |
| 33 | Disproportionate tall stature (HP:0001519) | 2.48196827 |
| 34 | Clumsiness (HP:0002312) | 2.48108459 |
| 35 | Bronchomalacia (HP:0002780) | 2.46751855 |
| 36 | Dilatation of the ascending aorta (HP:0005111) | 2.45707314 |
| 37 | Hemiparesis (HP:0001269) | 2.44065499 |
| 38 | Hemiplegia (HP:0002301) | 2.43268741 |
| 39 | Mitral regurgitation (HP:0001653) | 2.42488298 |
| 40 | Eczematoid dermatitis (HP:0000976) | 2.41522371 |
| 41 | Peritonitis (HP:0002586) | 2.40179848 |
| 42 | Arnold-Chiari malformation (HP:0002308) | 2.33480829 |
| 43 | Asymmetric septal hypertrophy (HP:0001670) | 2.31491606 |
| 44 | Lower limb amyotrophy (HP:0007210) | 2.30873615 |
| 45 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.28990104 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.28956018 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.26665450 |
| 48 | Premature skin wrinkling (HP:0100678) | 2.24956309 |
| 49 | Upper limb amyotrophy (HP:0009129) | 2.24202064 |
| 50 | Distal upper limb amyotrophy (HP:0007149) | 2.24202064 |
| 51 | Apathy (HP:0000741) | 2.19231623 |
| 52 | Wormian bones (HP:0002645) | 2.18708762 |
| 53 | Amyloidosis (HP:0011034) | 2.18643597 |
| 54 | Partial duplication of thumb phalanx (HP:0009944) | 2.18231526 |
| 55 | Fragile skin (HP:0001030) | 2.17633355 |
| 56 | Blue sclerae (HP:0000592) | 2.15511593 |
| 57 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.14730846 |
| 58 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.14730846 |
| 59 | Ankle contracture (HP:0006466) | 2.14148337 |
| 60 | Hyporeflexia of lower limbs (HP:0002600) | 2.12699180 |
| 61 | Intestinal fistula (HP:0100819) | 2.11453878 |
| 62 | Aplasia cutis congenita (HP:0001057) | 2.10908354 |
| 63 | Aplasia of the phalanges of the hand (HP:0009802) | 2.10120612 |
| 64 | Aplasia involving bones of the extremities (HP:0009825) | 2.10120612 |
| 65 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.10120612 |
| 66 | Difficulty climbing stairs (HP:0003551) | 2.09102482 |
| 67 | Rib fusion (HP:0000902) | 2.08370951 |
| 68 | Rapidly progressive (HP:0003678) | 2.07497207 |
| 69 | Hemorrhage of the eye (HP:0011885) | 2.05916742 |
| 70 | Thin bony cortex (HP:0002753) | 2.03956440 |
| 71 | Diminished motivation (HP:0000745) | 2.03327343 |
| 72 | Neonatal respiratory distress (HP:0002643) | 2.02694247 |
| 73 | Slender build (HP:0001533) | 2.01091032 |
| 74 | Esophageal atresia (HP:0002032) | 2.00842279 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 2.00764037 |
| 76 | Joint stiffness (HP:0001387) | 2.00028311 |
| 77 | Mitral valve prolapse (HP:0001634) | 1.99336578 |
| 78 | Hyperacusis (HP:0010780) | 1.98411078 |
| 79 | Vaginal fistula (HP:0004320) | 1.98098316 |
| 80 | Rectovaginal fistula (HP:0000143) | 1.97920035 |
| 81 | Rectal fistula (HP:0100590) | 1.97920035 |
| 82 | Macroorchidism (HP:0000053) | 1.97729140 |
| 83 | Zonular cataract (HP:0010920) | 1.95119320 |
| 84 | Genu recurvatum (HP:0002816) | 1.94910263 |
| 85 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.94896052 |
| 86 | Bladder diverticulum (HP:0000015) | 1.94767757 |
| 87 | Partial duplication of the phalanx of hand (HP:0009999) | 1.94134861 |
| 88 | Inflammation of the large intestine (HP:0002037) | 1.93667303 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 1.93565228 |
| 90 | Joint laxity (HP:0001388) | 1.91286388 |
| 91 | Amblyopia (HP:0000646) | 1.90846045 |
| 92 | Colitis (HP:0002583) | 1.88330166 |
| 93 | Polygenic inheritance (HP:0010982) | 1.88300374 |
| 94 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.87313815 |
| 95 | Deep venous thrombosis (HP:0002625) | 1.87204720 |
| 96 | Megalencephaly (HP:0001355) | 1.86947570 |
| 97 | Polycythemia (HP:0001901) | 1.86782863 |
| 98 | Easy fatigability (HP:0003388) | 1.86523202 |
| 99 | Pustule (HP:0200039) | 1.85826135 |
| 100 | Coxa vara (HP:0002812) | 1.84946028 |
| 101 | Short nail (HP:0001799) | 1.84329069 |
| 102 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.84317480 |
| 103 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.84317480 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.84317480 |
| 105 | Abnormality of complement system (HP:0005339) | 1.83389072 |
| 106 | Aortic regurgitation (HP:0001659) | 1.83276471 |
| 107 | Neonatal short-limb short stature (HP:0008921) | 1.82848897 |
| 108 | Spontaneous hematomas (HP:0007420) | 1.81990668 |
| 109 | Ulnar bowing (HP:0003031) | 1.81652767 |
| 110 | Emphysema (HP:0002097) | 1.80856341 |
| 111 | Renal salt wasting (HP:0000127) | 1.79735227 |
| 112 | Axonal loss (HP:0003447) | 1.79639011 |
| 113 | Glomerulonephritis (HP:0000099) | 1.79026900 |
| 114 | Round ear (HP:0100830) | 1.78957233 |
| 115 | Systemic lupus erythematosus (HP:0002725) | 1.77377830 |
| 116 | Premature rupture of membranes (HP:0001788) | 1.77326007 |
| 117 | Abnormality of macrophages (HP:0004311) | 1.76917705 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.76642599 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.76642599 |
| 120 | Exercise-induced myalgia (HP:0003738) | 1.76387265 |
| 121 | Turricephaly (HP:0000262) | 1.75570461 |
| 122 | Flat acetabular roof (HP:0003180) | 1.75143818 |
| 123 | Abnormality of the corticospinal tract (HP:0002492) | 1.75133702 |
| 124 | Nasal polyposis (HP:0100582) | 1.74113098 |
| 125 | Chin dimple (HP:0010751) | 1.74036898 |
| 126 | Onion bulb formation (HP:0003383) | 1.73759067 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.73372248 |
| 128 | Neuronal loss in central nervous system (HP:0002529) | 1.73185986 |
| 129 | Hyperextensible skin (HP:0000974) | 1.72319113 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.71446712 |
| 131 | Stridor (HP:0010307) | 1.69894912 |
| 132 | Mitral stenosis (HP:0001718) | 1.69132777 |
| 133 | Laryngomalacia (HP:0001601) | 1.67966878 |
| 134 | Arterial tortuosity (HP:0005116) | 1.67500605 |
| 135 | Chronic otitis media (HP:0000389) | 1.67204370 |
| 136 | Absent hand (HP:0004050) | 1.66431278 |
| 137 | Acanthosis nigricans (HP:0000956) | 1.66315079 |
| 138 | Persistence of primary teeth (HP:0006335) | 1.66266520 |
| 139 | Mutism (HP:0002300) | 1.65445363 |
| 140 | Biconcave vertebral bodies (HP:0004586) | 1.65430823 |
| 141 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.65421285 |
| 142 | Difficulty running (HP:0009046) | 1.65406553 |
| 143 | Prolonged bleeding time (HP:0003010) | 1.64989253 |
| 144 | Urethral obstruction (HP:0000796) | 1.64731169 |
| 145 | Bowing of the arm (HP:0006488) | 1.63887271 |
| 146 | Bowed forearm bones (HP:0003956) | 1.63887271 |
| 147 | Vascular tortuosity (HP:0004948) | 1.62903754 |
| 148 | Overgrowth (HP:0001548) | 1.62525071 |
| 149 | Mucopolysacchariduria (HP:0008155) | 1.62294080 |
| 150 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.62294080 |
| 151 | Soft skin (HP:0000977) | 1.62242803 |
| 152 | Bulbar palsy (HP:0001283) | 1.62128200 |
| 153 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.61878123 |
| 154 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.61701356 |
| 155 | Bilateral microphthalmos (HP:0007633) | 1.61259589 |
| 156 | Foot dorsiflexor weakness (HP:0009027) | 1.60455816 |
| 157 | Striae distensae (HP:0001065) | 1.60146451 |
| 158 | Fused cervical vertebrae (HP:0002949) | 1.59971172 |
| 159 | Metabolic alkalosis (HP:0200114) | 1.58851176 |
| 160 | Coronal craniosynostosis (HP:0004440) | 1.58596712 |
| 161 | Achilles tendon contracture (HP:0001771) | 1.58385995 |
| 162 | Gastrointestinal atresia (HP:0002589) | 1.57535816 |
| 163 | Hypokalemic alkalosis (HP:0001949) | 1.55837018 |
| 164 | Cellulitis (HP:0100658) | 1.54923824 |
| 165 | Lower limb asymmetry (HP:0100559) | 1.53913793 |
| 166 | Broad metatarsal (HP:0001783) | 1.53328045 |
| 167 | Anteriorly placed anus (HP:0001545) | 1.53157711 |
| 168 | Abnormality of the axillary hair (HP:0100134) | 1.52229300 |
| 169 | Abnormality of secondary sexual hair (HP:0009888) | 1.52229300 |
| 170 | Infantile muscular hypotonia (HP:0008947) | 1.51164629 |
| 171 | Akinesia (HP:0002304) | 1.50871868 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAPK15 | 3.12416821 |
| 2 | EPHB1 | 3.07312104 |
| 3 | SIK1 | 2.88634213 |
| 4 | TGFBR2 | 2.79718816 |
| 5 | PRPF4B | 2.57730700 |
| 6 | TRIB3 | 1.94989117 |
| 7 | MAP4K1 | 1.94932879 |
| 8 | RIPK1 | 1.76374348 |
| 9 | MAP2K3 | 1.76225590 |
| 10 | SMG1 | 1.72613194 |
| 11 | STK10 | 1.70985498 |
| 12 | CLK1 | 1.69786219 |
| 13 | MST4 | 1.69682092 |
| 14 | PRKD2 | 1.68072616 |
| 15 | MAP3K10 | 1.67489068 |
| 16 | SIK2 | 1.62100172 |
| 17 | ICK | 1.56237458 |
| 18 | GRK7 | 1.54773410 |
| 19 | MAP3K3 | 1.54038449 |
| 20 | MATK | 1.50390030 |
| 21 | CSK | 1.50243729 |
| 22 | FGR | 1.47994061 |
| 23 | CDC42BPA | 1.47212789 |
| 24 | GRK6 | 1.47113576 |
| 25 | HIPK2 | 1.47025468 |
| 26 | FES | 1.41919563 |
| 27 | MARK2 | 1.41892778 |
| 28 | BLK | 1.40018747 |
| 29 | FGFR4 | 1.37125376 |
| 30 | MAP3K6 | 1.36255542 |
| 31 | BMX | 1.34929517 |
| 32 | IRAK3 | 1.29580147 |
| 33 | TESK1 | 1.27960698 |
| 34 | MOS | 1.25555576 |
| 35 | PDGFRA | 1.23909154 |
| 36 | CSF1R | 1.22579653 |
| 37 | TBK1 | 1.21213276 |
| 38 | NTRK1 | 1.17386492 |
| 39 | TNK2 | 1.14644252 |
| 40 | DMPK | 1.14347827 |
| 41 | ERN1 | 1.11176747 |
| 42 | UHMK1 | 1.11124719 |
| 43 | TYRO3 | 1.10253076 |
| 44 | LRRK2 | 1.09569177 |
| 45 | NTRK2 | 1.08405305 |
| 46 | CASK | 1.07849342 |
| 47 | STK38 | 1.05269753 |
| 48 | MAP2K2 | 1.04872047 |
| 49 | MAP3K11 | 1.04527988 |
| 50 | RPS6KA2 | 1.03860820 |
| 51 | PAK2 | 1.02587649 |
| 52 | MST1R | 1.00773239 |
| 53 | EEF2K | 1.00389321 |
| 54 | ARAF | 0.99026532 |
| 55 | LMTK2 | 0.98140039 |
| 56 | CAMK1G | 0.96787983 |
| 57 | PRKD3 | 0.95920445 |
| 58 | PKN1 | 0.95206971 |
| 59 | PDPK1 | 0.94667934 |
| 60 | KSR2 | 0.93692863 |
| 61 | GSK3A | 0.93122406 |
| 62 | MAPK7 | 0.90857979 |
| 63 | MYLK | 0.90253221 |
| 64 | PKN2 | 0.89199984 |
| 65 | HCK | 0.88197039 |
| 66 | TNIK | 0.87644956 |
| 67 | PRKD1 | 0.86151489 |
| 68 | ZAP70 | 0.85348347 |
| 69 | GRK5 | 0.84511571 |
| 70 | ROCK2 | 0.84284226 |
| 71 | TAOK2 | 0.83907181 |
| 72 | DYRK1B | 0.82870229 |
| 73 | IKBKE | 0.82741176 |
| 74 | TAOK1 | 0.82485391 |
| 75 | LATS2 | 0.82315337 |
| 76 | DDR2 | 0.81872480 |
| 77 | PTK6 | 0.81269091 |
| 78 | MAP3K7 | 0.81248609 |
| 79 | MTOR | 0.80222250 |
| 80 | PTK2 | 0.79186712 |
| 81 | MAP3K14 | 0.79134854 |
| 82 | KIT | 0.78697620 |
| 83 | JAK1 | 0.78289455 |
| 84 | MUSK | 0.77032242 |
| 85 | CAMKK1 | 0.77012983 |
| 86 | LCK | 0.72750194 |
| 87 | PDGFRB | 0.72197799 |
| 88 | PAK4 | 0.72135915 |
| 89 | CAMK4 | 0.68978665 |
| 90 | MAPKAPK5 | 0.68687602 |
| 91 | MAP3K13 | 0.67348578 |
| 92 | IRAK2 | 0.66936324 |
| 93 | CAMK1 | 0.65649370 |
| 94 | RPS6KC1 | 0.65455388 |
| 95 | RPS6KL1 | 0.65455388 |
| 96 | STK11 | 0.65423496 |
| 97 | CDK12 | 0.65417556 |
| 98 | RET | 0.64203816 |
| 99 | PRKG2 | 0.62670577 |
| 100 | ALK | 0.62029166 |
| 101 | MAPK12 | 0.60538913 |
| 102 | SGK3 | 0.59780947 |
| 103 | IRAK4 | 0.59645089 |
| 104 | EPHA3 | 0.59467727 |
| 105 | PTK2B | 0.59350429 |
| 106 | CHUK | 0.59182155 |
| 107 | MAPK4 | 0.58622549 |
| 108 | MAP3K1 | 0.57621149 |
| 109 | IKBKB | 0.57595595 |
| 110 | PIM2 | 0.57126826 |
| 111 | PHKG2 | 0.56582557 |
| 112 | PHKG1 | 0.56582557 |
| 113 | EPHB2 | 0.56141774 |
| 114 | FGFR2 | 0.55770905 |
| 115 | NEK9 | 0.55596059 |
| 116 | PDK1 | 0.54891582 |
| 117 | FGFR3 | 0.54710443 |
| 118 | PRKCH | 0.54173631 |
| 119 | EPHA2 | 0.53927254 |
| 120 | INSR | 0.53429451 |
| 121 | DAPK3 | 0.52923922 |
| 122 | PAK6 | 0.52715555 |
| 123 | ITK | 0.52280862 |
| 124 | TRPM7 | 0.52039818 |
| 125 | JAK3 | 0.50217916 |
| 126 | CDK5 | 0.50154626 |
| 127 | MET | 0.48803998 |
| 128 | MAP3K2 | 0.48518092 |
| 129 | ROCK1 | 0.48330561 |
| 130 | MARK1 | 0.47868216 |
| 131 | FYN | 0.47620500 |
| 132 | EGFR | 0.46840739 |
| 133 | RPS6KA6 | 0.46204955 |
| 134 | OXSR1 | 0.45971511 |
| 135 | STK39 | 0.45640808 |
| 136 | NLK | 0.45477669 |
| 137 | ABL2 | 0.44725347 |
| 138 | TYK2 | 0.44698470 |
| 139 | RIPK4 | 0.44415725 |
| 140 | DYRK2 | 0.44133346 |
| 141 | TTN | 0.43999248 |
| 142 | LIMK1 | 0.42430156 |
| 143 | SIK3 | 0.42285595 |
| 144 | MAPKAPK3 | 0.40851221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.07189442 |
| 2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.07177648 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.03929752 |
| 4 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.94228874 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59848691 |
| 6 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.43244629 |
| 7 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.40717116 |
| 8 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.39913545 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.38030171 |
| 10 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.37493035 |
| 11 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.37174184 |
| 12 | Axon guidance_Homo sapiens_hsa04360 | 1.36832136 |
| 13 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.34551803 |
| 14 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.32764102 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.31739961 |
| 16 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.27974753 |
| 17 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.27920029 |
| 18 | Focal adhesion_Homo sapiens_hsa04510 | 1.26504974 |
| 19 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22986869 |
| 20 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.22209653 |
| 21 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.20418140 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14980888 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.14617822 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.11840743 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.11653782 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.10871928 |
| 27 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.10124888 |
| 28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09143478 |
| 29 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.07868873 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.06426030 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05519344 |
| 32 | Glioma_Homo sapiens_hsa05214 | 1.05248333 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04246606 |
| 34 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.03848321 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03364442 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02926569 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01532580 |
| 38 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.01131966 |
| 39 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01055623 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.00695412 |
| 41 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.00196603 |
| 42 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.00176886 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.99733581 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98435971 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.97199714 |
| 46 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96730973 |
| 47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.96207249 |
| 48 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.94942858 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.94939364 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.93815169 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.92540203 |
| 52 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92276037 |
| 53 | Long-term depression_Homo sapiens_hsa04730 | 0.91536438 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.91432301 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.91039060 |
| 56 | Endocytosis_Homo sapiens_hsa04144 | 0.90929838 |
| 57 | Renin secretion_Homo sapiens_hsa04924 | 0.90053459 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.89630191 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89380843 |
| 60 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.88980449 |
| 61 | Leishmaniasis_Homo sapiens_hsa05140 | 0.88737629 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.88561909 |
| 63 | Adherens junction_Homo sapiens_hsa04520 | 0.88184332 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.88038633 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 0.84606657 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84287739 |
| 67 | Bladder cancer_Homo sapiens_hsa05219 | 0.84022328 |
| 68 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.83376074 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83320567 |
| 70 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.83135453 |
| 71 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82971402 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82422525 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82318850 |
| 74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81694852 |
| 75 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.81415546 |
| 76 | Melanogenesis_Homo sapiens_hsa04916 | 0.80981976 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.80112786 |
| 78 | Pathways in cancer_Homo sapiens_hsa05200 | 0.79644374 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.78312621 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77867312 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.77677048 |
| 82 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77456710 |
| 83 | Pertussis_Homo sapiens_hsa05133 | 0.77308757 |
| 84 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77283397 |
| 85 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76622615 |
| 86 | Shigellosis_Homo sapiens_hsa05131 | 0.76470873 |
| 87 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76133746 |
| 88 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.75900935 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75620467 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.75573558 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75434925 |
| 92 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75009956 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74933827 |
| 94 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74851168 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.74624050 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73877780 |
| 97 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73209770 |
| 98 | Malaria_Homo sapiens_hsa05144 | 0.71507454 |
| 99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.71454675 |
| 100 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71357708 |
| 101 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.71011512 |
| 102 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.70536822 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.70372781 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.70201981 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69820931 |
| 106 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.69495777 |
| 107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.68957910 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.68549368 |
| 109 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68419838 |
| 110 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.66581437 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.66343895 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.66170256 |
| 113 | Phagosome_Homo sapiens_hsa04145 | 0.65990019 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64439567 |
| 115 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64159035 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64062870 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63778978 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63673078 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63437181 |
| 120 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62622440 |
| 121 | Hepatitis B_Homo sapiens_hsa05161 | 0.62359609 |
| 122 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61698343 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.60730977 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.60409783 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.60019427 |
| 126 | Long-term potentiation_Homo sapiens_hsa04720 | 0.59966935 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.59373561 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57438236 |
| 129 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.57174960 |

